View Older Stories View More Recent Stories

Jul 13, 2018 06:24PM Akers Biosciences Files Restated Previously Issued Financial Statements for 2017
Jul 3, 2018 07:00AM Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
Jun 29, 2018 07:00AM Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange
May 30, 2018 06:09PM Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
May 29, 2018 07:08AM Akers Biosciences (AKER) Announces Raymond Akers has Resigned as Director
May 29, 2018 07:01AM Akers Biosciences (AKER) Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
May 29, 2018 07:00AM Akers Biosciences Announces a Change to the Board of Directors
May 29, 2018 07:00AM Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
May 25, 2018 04:30PM Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
Apr 12, 2018 07:00AM Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
Apr 3, 2018 07:03AM Akers Biosciences Reports Earnings for Fiscal Year 2017
Mar 28, 2018 11:20AM Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings
Mar 26, 2018 07:05AM Akers Biosciences (AKER) Enters US Distribution Agreement with Diagnostica Stago
Mar 26, 2018 07:00AM Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago
Mar 15, 2018 01:11PM Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings
Dec 21, 2017 04:58PM Akers Biosciences Announces Closing of $6,900,000 Public Offering
Dec 18, 2017 10:01PM Akers Biosciences Prices $6,000,000 Public Offering
Dec 8, 2017 10:31AM Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line
Nov 15, 2017 07:00AM Akers Biosciences Announces Q3 2017 Earnings
Nov 14, 2017 07:00AM Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer
Nov 13, 2017 09:00AM Akers Biosciences Announces Conference Call to Discuss Q3 2017 Earnings
Sep 7, 2017 07:00AM Akers Biosciences Hires Medical Device Specialist to Lead US Sales and Distribution
Aug 15, 2017 07:00AM Akers Biosciences Announces Q2 2017 Earnings
Aug 8, 2017 07:00AM Akers Biosciences Announces Board Changes
Aug 3, 2017 11:39AM Akers Biosciences Announces Second Quarter Trading Update
May 16, 2017 07:00AM Akers Biosciences Announces Q1 2017 Earnings
May 12, 2017 09:36AM Akers Biosciences Announces Conference Call to Discuss Q1 2017 Earnings
Apr 24, 2017 07:00AM Akers Biosciences Updates on Akers Wellness(TM) Tests
Apr 11, 2017 07:00AM Akers Biosciences Reports Earnings for Fiscal Year 2016
Apr 10, 2017 10:00AM Akers Biosciences Announces Conference Call to Discuss FY 2016 Earnings
Apr 10, 2017 07:00AM Akers Biosciences to Commercialize Heparin PF4 Rapid Test in Puerto Rico
Mar 30, 2017 04:27PM Akers Biosciences (AKER) Announces $2M Private Placement
Mar 30, 2017 04:25PM Akers Biosciences Announces a $2 Million Private Placement
Mar 30, 2017 08:30AM Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016
Mar 29, 2017 07:00AM Akers Biosciences Announces Conference Call to Discuss FY 2016 Earnings
Mar 28, 2017 07:04AM Akers Biosciences (AKER) Receives Initial Order for First Check Rapid Cholesterol Test
Mar 28, 2017 07:00AM Akers Biosciences Begins Selling Rapid Cholesterol Test through Distribution Agreement with First Check
Feb 16, 2017 07:00AM Akers Biosciences Allowed US Patent for Akers Wellness(TM) Tests Cartridge
Jan 13, 2017 04:21PM Akers Biosciences Announces Closing of Public Offering
Jan 10, 2017 05:52AM Akers Biosciences (AKER) Sells ~1.67M Shares at $1.20, Plus Warrants
Jan 9, 2017 07:58PM Akers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants
Dec 22, 2016 07:03AM Akers Biosciences (AKER) Enters 3-Year Deal with GNYHA for Heparin PF4 Rapid Test
Dec 22, 2016 07:00AM Akers Biosciences Signs 3-year Agreement with GNYHA Services for Heparin PF4 Rapid Test
Dec 19, 2016 07:13AM Akers Biosciences (AKER) Signs Three Agreement with GNYHA to Introduce Heparin PF4 Rapid Test
Dec 19, 2016 07:00AM Akers Biosciences Signs 3-year Agreement with Greater New York Hospital Association for Heparin PF4 Rapid Test
Dec 1, 2016 07:02AM Akers Biosciences (AKER) Enters Distribution Agreement with First Check Diagnostics
Dec 1, 2016 07:00AM Akers Biosciences Signs Distribution Agreement with First Check Diagnostics for Rapid Cholesterol Test
Nov 28, 2016 07:07AM Akers Biosciences (AKER) Announces Completion of BreathScan DKA Trial; Results Seen as 'Highly Successful'
Nov 28, 2016 07:00AM Akers Biosciences Completes Clinical Trial for Rapid Diabetic Ketoacidosis Breath Test
Nov 14, 2016 07:00AM Akers Biosciences Announces Q3 Earnings
View More Recent Stories View Older Stories